共 4 条
[1]
Chemoradiotherapy for lung cancer: current status and perspectives[J] . Yuichiro Ohe.International Journal of Clinical Oncology . 2004 (6)
[2]
Activated extracellular signal-regulated kinases:association with epidermal growth fac-tor receptor/transforming growth factorαexpressionin head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treat ment .2 Albanell J,Codony-Servat J,Rojo F,et al. Cancer Res . 2001
[3]
Bevacizumab,when added to paclitaxel/carboplatin,prolongs survival in previously untreated petients with advanced non-small cell lung cancer:preli minary results fromthe ECOG4599trial .2 Tyagi P. Clin Lung Cancer . 2005
[4]
Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839in healthy volunteers .2 Swaisland H,Laight A,Stafford L,et al. Clin Pharmacokinet . 2001